OPKO Health Reports 2016 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Opko Health (OPK) PT Lowered to $8 at Jefferies Following 4Q Miss
March 2, 2017 7:38 AM ESTJefferies lowered its price target on Opko Health (NASDAQ: OPK) to $8.00 (from $10.00) while maintaining a Hold rating. 4Q revenues of $275M came in well below consensus estimates, mainly on weaker BRLI trends.
Analyst Brandon Couillard commented, "4Q16 revenues came in well below... More
OPKO Health (OPK) Reports In-Line Q4 EPS
March 1, 2017 4:19 PM ESTOPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $275.5 million versus the consensus estimate of $310.82 million.
Consolidated revenues for the three months ended December 31, 2016 of $275.5 million were consistent with the comparable period of 2015 revenue of $276.2 million. The 2016 period benefited from... More